|
|
| 47.63 Real-Time Quote |  +0.40 / +0.85%Today’s Change | 40.70 Today|||52-Week Range 57.34 | +14.58% Year-to-Date |
| ResMed Expands in Czech-Slovak Markets - Analyst Blog Dec 03 / Zacks.com | Frontrunning: December 2 Dec 02 / Investing Channel |
| Previous close | 47.23 |
| Today’s open | 47.20 |
| Day’s range | 47.20 - 47.76 |
| Volume | 110,661 |
| Average volume (3 months) | 1,199,550 |
| Market cap | $6.7B |
| Dividend yield | 2.10% |
| Earnings growth (last year) | +22.81% |
| Earnings growth (this year) | +13.32% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +10.66% |
| P/E ratio | 22.1 |
| Price/Sales | 4.26 |
| Price/Book | 4.16 |
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | +0.66 | +0.84% |
| TFXTeleflex Inc | +1.26 | +1.31% |
| THORThoratec Corp | -0.16 | -0.41% |
| CYBXCyberonics Inc | +0.24 | +0.35% |
| Next reporting date | February 6, 2014 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | $307.1M |
| Net profit margin | 20.28% |
Sector Health Technology |
Industry Medical Specialties |
Executive Chairman Peter C. Farrell |
Chief Executive Officer & Director Michael J. Farrell |
Corporate headquarters San Diego, California |
.
